These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19557144)

  • 1. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.
    Hardeland R
    Neuropsychiatr Dis Treat; 2009; 5():341-54. PubMed ID: 19557144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonergic drugs in clinical practice.
    Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
    Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches.
    Hardeland R
    Curr Pharm Des; 2016; 22(8):1086-101. PubMed ID: 25248806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
    Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin receptor agonists: new options for insomnia and depression treatment.
    Spadoni G; Bedini A; Rivara S; Mor M
    CNS Neurosci Ther; 2011 Dec; 17(6):733-41. PubMed ID: 21554566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
    Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin receptors, brain functions, and therapies.
    Oishi A; Gbahou F; Jockers R
    Handb Clin Neurol; 2021; 179():345-356. PubMed ID: 34225974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin and its analogs in insomnia and depression.
    Cardinali DP; Srinivasan V; Brzezinski A; Brown GM
    J Pineal Res; 2012 May; 52(4):365-75. PubMed ID: 21951153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin
    Quera-Salva MA; Claustrat B
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin agonists and insomnia.
    Ferguson SA; Rajaratnam SM; Dawson D
    Expert Rev Neurother; 2010 Feb; 10(2):305-18. PubMed ID: 20136385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of melatonin agonists.
    Cardinali DP; Pandi-Perumal SR; Srinivasan V; Spence DW; Trakht I
    Expert Rev Endocrinol Metab; 2008 Mar; 3(2):269-279. PubMed ID: 30764095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the melatonin system in the control of sleep: therapeutic implications.
    Pandi-Perumal SR; Srinivasan V; Spence DW; Cardinali DP
    CNS Drugs; 2007; 21(12):995-1018. PubMed ID: 18020480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse.
    Cardinali DP; Golombek DA; Rosenstein RE; Brusco LI; Vigo DE
    Pharmacol Res; 2016 Jul; 109():12-23. PubMed ID: 26438969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramelteon: profile of a new sleep-promoting medication.
    Owen RT
    Drugs Today (Barc); 2006 Apr; 42(4):255-63. PubMed ID: 16703122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tasimelteon for treating non-24-h sleep-wake rhythm disorder.
    Nishimon S; Nishimon M; Nishino S
    Expert Opin Pharmacother; 2019 Jun; 20(9):1065-1073. PubMed ID: 30990759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of insomnia with ramelteon: safety, efficacy and clinical applications.
    Pandi-Perumal SR; Spence DW; Verster JC; Srinivasan V; Brown GM; Cardinali DP; Hardeland R
    J Cent Nerv Syst Dis; 2011; 3():51-65. PubMed ID: 23861638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.
    Srinivasan V; Zakaria R; Othaman Z; Brzezinski A; Prasad A; Brown GM
    CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):180-9. PubMed ID: 22483286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood.
    Alston M; Cain SW; Rajaratnam SMW
    Handb Exp Pharmacol; 2019; 253():305-319. PubMed ID: 31123831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.